Divalproex Sodium: Again setback to Nupharm

Nu-Pharm Inc.’s efforts to get USFDA to approve the company’s ANDA for the generic version of Abbott Laboratories’ Depakote (divalproex sodium) Delayed-Release Tablets 500 mg were earlier rejected by District court of Columbia earlier in Jan 2008. On April 17, 2008, a 3-judge panel from the U.S. Court of Appeals for the District of Columbia Circuit issued an order granting FDA’s Motion for Summary Affirmance. The court decision here